Generation Bio Co.
(GBIO)
undefined
undefined%
At close: undefined
1.21
5.27%
After-hours Dec 13, 2024, 04:26 PM EST
Company Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases.
The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina.
It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.
The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.
Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co.
| Country | United States |
| IPO Date | Jun 12, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 174 |
| CEO | Dr. Cameron Geoffrey McDonough M.D. |
Contact Details
Address: 301 Binney Street Cambridge, Massachusetts United States | |
| Website | https://generationbio.com |
Stock Details
| Ticker Symbol | GBIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001733294 |
| CUSIP Number | 37148K100 |
| ISIN Number | US37148K1007 |
| Employer ID | 81-4301281 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Cameron Geoffrey McDonough M.D. | President, Chief Executive Officer & Director |
| Antoinette Paone M.B.A., M.S. | Chief Operating Officer |
| Dr. Matthew Norkunas M.B.A., M.D. | Chief Financial Officer |
| Yalonda Howze J.D. | Chief Legal Officer & Secretary |
| Dr. Mark D. Angelino Ph.D. | Co-Founder |
| Dr. Matthew Stanton Ph.D. | Chief Scientific Officer |
| Dr. Phillip Samayoa Ph.D. | Chief Strategy Officer |
| Dr. Robert Kotin Ph.D. | Co-Founder |
| Jasmin Tower | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 09, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 06, 2024 | 10-Q | Quarterly Report |
| Nov 06, 2024 | 8-K | Current Report |
| Oct 23, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 17, 2024 | 4 | Filing |
| Oct 17, 2024 | 4 | Filing |
| Oct 17, 2024 | 4 | Filing |
| Oct 17, 2024 | 4 | Filing |